Plenty of deceit passed on by Nader and Kelly. So much so that the FDA rebuked statements made by Nader not once, BUT TWICE.
Cytodyn is in massive trouble. Little Cash, more debt than assets, no means to raise substantial funds, no CEO, no approvals on the horizon or otherwise positive catalysts. Oh. SEC and DOJ investigations looming.
It is great to have a PMA, but ignoring the company’ s own statements in their public filings regarding investigations and financial condition is incomprehensible.